RecruitingNot ApplicableNCT07788729

Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons

PRISMA - A Pilot Randomized Phase II Trial on Social Prescriptions and Micro- Learning to Improve Care for Cancer Patients and Their Support Persons


Sponsor

University of Regensburg

Enrollment

384 participants

Start Date

Apr 21, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Optimal patient-centered care is often not being delivered to cancer patients, especially to vulnerable populations like those living in underserved rural areas. This body of work will develop and pilot test a multicomponent intervention approach designed to improve the care and outcomes of cancer patients and their support persons (SPs) during and following their therapeutic journey. The intervention will involve the provision of social prescriptions and web-based micro-learning modules, as well as stepwise care based on ongoing monitoring of symptom burden and health. This project uses the strengths of innovative, individually tailored communication strategies and a comprehensive low-cost approach that are likely to support fair and equal patient access to optimal care beyond the funding period. By using a patient-driven approach in an interdisciplinary setting, it is anticipated that the intervention will improve the health outcomes of various patient populations, especially those living in rural areas. To achieve this, a methodologically robust mixed-methods approach and an effectiveness-implementation hybrid design will be employed to move effective strategies towards implementation into clinical practice. A number of standardized patient-reported outcome and experience measures will be used, including quality of life and knowledge of health and care. As a result of this research, an implementation toolbox will be developed that could be used by clinicians working in different healthcare settings and services, both nationally and internationally, to help provide highest quality cancer care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying PRISMA-interventions for people with cancer, colorectal, cancer, and other related conditions. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPRISMA-interventions

A multicomponent intervention including social prescriptions, web-based micro-learning modules, and stepwise care based on symptom monitoring.


Locations(8)

University Hospital Augsburg

Augsburg, Bavaria, Germany

University Hospital Erlangen

Erlangen, Bavaria, Germany

University Hospital Regensburg

Regensburg, Bavaria, Germany

University Regensburg

Regensburg, Bavaria, Germany

University Hospital Würzburg

Würzburg, Bavaria, Germany

Faculty of Law, Business & Economics, Inst. for Healthcare Management & Health Sciences

Bayreuth, Germany

Charité - University Medicine Berlin

Berlin, Germany

University Hospital Köln

Cologne, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07788729


Related Trials